![Safety of Celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance | Allergologia et Immunopathologia Safety of Celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance | Allergologia et Immunopathologia](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/13108222:105v35n04-13108222tab02.gif?idApp=UINPBA00004N)
Safety of Celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance | Allergologia et Immunopathologia
![Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Celecoxib in Rats | Drug Metabolism & Disposition Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Celecoxib in Rats | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/28/5/514/F4.large.jpg)
Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Celecoxib in Rats | Drug Metabolism & Disposition
![Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib | Annals of the Rheumatic Diseases Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/63/11/1419/F3.large.jpg)
Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib | Annals of the Rheumatic Diseases
![The Effects of Celecoxib or Naproxen on Blood Pressure in Pediatric Patients with Juvenile Idiopathic Arthritis - B. Falkner, M. Berger, P. Bhadra Brown, D. Iorga, R.W. Nickeson, L. Zemel, 2015 The Effects of Celecoxib or Naproxen on Blood Pressure in Pediatric Patients with Juvenile Idiopathic Arthritis - B. Falkner, M. Berger, P. Bhadra Brown, D. Iorga, R.W. Nickeson, L. Zemel, 2015](https://journals.sagepub.com/cms/10.4137/CMPed.S20720/asset/images/large/10.4137_cmped.s20720-fig3.jpeg)
The Effects of Celecoxib or Naproxen on Blood Pressure in Pediatric Patients with Juvenile Idiopathic Arthritis - B. Falkner, M. Berger, P. Bhadra Brown, D. Iorga, R.W. Nickeson, L. Zemel, 2015
![These highlights do not include all the information needed to use CELECOXIB CAPSULES safely and effectively. See full prescribing information for CELECOXIB CAPSULES. CELECOXIB capsules, for oral use Initial U.S. Approval: 1998 These highlights do not include all the information needed to use CELECOXIB CAPSULES safely and effectively. See full prescribing information for CELECOXIB CAPSULES. CELECOXIB capsules, for oral use Initial U.S. Approval: 1998](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=celecoxib-400mg-60s-bottle.jpg&id=687544)
These highlights do not include all the information needed to use CELECOXIB CAPSULES safely and effectively. See full prescribing information for CELECOXIB CAPSULES. CELECOXIB capsules, for oral use Initial U.S. Approval: 1998
![Pharmaceutics | Free Full-Text | Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib Pharmaceutics | Free Full-Text | Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-01043/article_deploy/html/images/pharmaceutics-12-01043-g001-550.jpg)
Pharmaceutics | Free Full-Text | Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib
![WO2009063367A1 - Dosage forms comprising celecoxib providing both rapid and sustained pain relief - Google Patents WO2009063367A1 - Dosage forms comprising celecoxib providing both rapid and sustained pain relief - Google Patents](https://patentimages.storage.googleapis.com/13/36/b1/b8f08572f58940/imgf000038_0001.png)
WO2009063367A1 - Dosage forms comprising celecoxib providing both rapid and sustained pain relief - Google Patents
![Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/21bff47b-52e2-4d1f-b271-23ecf9014267/joim13505-fig-0003-m.jpg)